Totaligent, INC 8-K filings

Totaligent, Inc. has entered into a definitive agreement to acquire the assets of Aetherium Medical, appointing Ivan Klarich as President and a board member.

Totaligent, Inc. has extended the target date for its proposed acqui-hire transaction with Aetherium Medical to April 10, 2026, to allow for additional due diligence and negotiations.

Totaligent, Inc. announced an extension to the binding letter of intent with Aetherium Medical, pushing the target closing date for their proposed acqui-hire transaction to March 20, 2026.

Totaligent, Inc. has entered a binding letter of intent to form a joint venture with GloMed Solutions Limited Liability Company to expand its Aetherium Medical platform into high-growth APAC markets, alongside a call option to acquire GloMed.

Totaligent, Inc. has entered a binding letter of intent to acquire Aetherium Medical's team, intellectual property, and assets in an all-equity acqui-hire transaction.

Totaligent, Inc. has entered into a six-month agreement with 247MarketNews for investor and public relations services, compensating the consultant with 5 million shares of restricted common stock.

Totaligent, Inc. has entered into an agreement with Karolus Maximus Kapital, Inc. to limit the investor's ability to convert promissory notes into common stock, capping ownership at 4.99%.

Totaligent, Inc. announces the election of Brian Heckathorne as a director and the resignation of Ben Hansel, both effective April 18, 2025.